» Articles » PMID: 24203698

Dual-tagged Amyloid-β Precursor Protein Reveals Distinct Transport Pathways of Its N- and C-terminal Fragments

Overview
Journal Hum Mol Genet
Date 2013 Nov 9
PMID 24203698
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The amyloid-β precursor protein (APP), a type I transmembrane protein genetically associated with Alzheimer's disease, has a complex biology that includes proteolytic processing into potentially toxic fragments, extensive trafficking and multiple, yet poorly-defined functions. We recently proposed that a significant fraction of APP is proteolytically cleaved in the neuronal soma into N- and C-terminal fragments (NTFs and CTFs), which then target independently of each other to separate destinations in the cell. Here, we prove this concept with live imaging and immunolocalization of two dual, N- and C-termini-tagged APP constructs: CFP-APP-YFP [containing the fluorescent tags, cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP)] and FLAG-APP-Myc. When expressed at low levels in neuronal cells, these constructs are processed into differently tagged NTFs and CTFs that reveal distinct distributions and characteristics of transport. Like the endogenous N- and C-terminal epitopes of APP, the FLAG-tagged NTFs are present in trains of vesicles and tubules that localize to short filaments, which often immunostain for acetylated tubulin, whereas the Myc-tagged CTFs are detected on randomly distributed vesicle-like structures. The experimental treatments that selectively destabilize the acetylated microtubules abrogate the distribution of NTFs along filaments, without altering the random distribution of CTFs. These results indicate that the NTFs and CTFs are recruited to distinct transport pathways and reach separate destinations in neurons, where they likely accomplish functions independent of the parental, full-length APP. They also point to a compartment associated with acetylated microtubules in the neuronal soma--not the neurite terminals--as a major site of APP cleavage, and segregation of NTFs from CTFs.

Citing Articles

Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations.

Wang J, Fourriere L, Gleeson P Biochem J. 2024; 481(19):1297-1325.

PMID: 39302110 PMC: 11555708. DOI: 10.1042/BCJ20240056.


Molecular probes for cellular imaging of post-translational proteoforms.

Suraritdechachai S, Lakkanasirorat B, Uttamapinant C RSC Chem Biol. 2022; 3(2):201-219.

PMID: 35360891 PMC: 8826509. DOI: 10.1039/d1cb00190f.


Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging.

DelBove C, Strothman C, Lazarenko R, Huang H, Sanders C, Zhang Q Neurobiol Dis. 2019; 127:449-461.

PMID: 30885793 PMC: 6588454. DOI: 10.1016/j.nbd.2019.03.009.


Direct imaging of APP proteolysis in living cells.

Parenti N, Del Grosso A, Antoni C, Cecchini M, Corradetti R, Pavone F PeerJ. 2017; 5:e3086.

PMID: 28413720 PMC: 5391788. DOI: 10.7717/peerj.3086.


Amyloid Precursor Proteins Are Dynamically Trafficked and Processed during Neuronal Development.

Ramaker J, Cargill R, Swanson T, Quirindongo H, Cassar M, Kretzschmar D Front Mol Neurosci. 2016; 9:130.

PMID: 27932950 PMC: 5122739. DOI: 10.3389/fnmol.2016.00130.


References
1.
Park Y, Jeong J, Lee H, Mun J, Kim J, Lee J . Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin. Proc Natl Acad Sci U S A. 2010; 107(41):17785-90. PMC: 2955093. DOI: 10.1073/pnas.1004361107. View

2.
Soppina V, Herbstman J, Skiniotis G, Verhey K . Luminal localization of α-tubulin K40 acetylation by cryo-EM analysis of fab-labeled microtubules. PLoS One. 2012; 7(10):e48204. PMC: 3482196. DOI: 10.1371/journal.pone.0048204. View

3.
Vetrivel K, Thinakaran G . Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments. Neurology. 2006; 66(2 Suppl 1):S69-73. DOI: 10.1212/01.wnl.0000192107.17175.39. View

4.
Whitmarsh A, Cavanagh J, Tournier C, Yasuda J, Davis R . A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 1998; 281(5383):1671-4. DOI: 10.1126/science.281.5383.1671. View

5.
Braak H, Del Tredici K . Where, when, and in what form does sporadic Alzheimer's disease begin?. Curr Opin Neurol. 2012; 25(6):708-14. DOI: 10.1097/WCO.0b013e32835a3432. View